References
- World Health Organization, World malaria report, December 2022; https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022; last access date March 30, 2023.
- World Health Organization, Cancer, February 2022; https://www.who.int/news-room/fact-sheets/detail/cancer; last access date March 30, 2023.
- N. Vasan, J. Baselga and D. M. Hyman, A view on drug resistance in cancer, Nature 575(7782) (2019) 299–309; https://doi.org/10.1038/s41586-019-1730-1
- Y. Le Govic, S. Houzé and N. Papon, Repurposing anticancer drugs to tackle malaria, ChemMed-Chem 16(14) (2021) 2192–2194; https://doi.org/10.1002/cmdc.202100176
- T. Ellis, E. Eze and B. T. Raimi-Abraham, Malaria and cancer: a critical review on the established associations and new perspectives, Infect. Agent Cancer 16(33) (2021) (14 pages); https://doi.org/10.1186/s13027-021-00370-7
- C. Verbaanderd, H. Maes, M. B. Schaaf, V. P. Sukhatme, P. Pantziarka, V. Sukhatme, P. Agostinis and G. Bouche, Repurposing drugs in oncology (ReDO) – chloroquine and hydroxychloroquine as anti-cancer agents, Ecancermedicalscience 23(11) (2017) Article ID 781 (35 pages); https://doi.org/10.3332/ecancer.2017.781
- H. Monma, Y. Iida, T. Moritani, T. Okimoto, R. Tanino, Y. Tajima and H. Mamoru, Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cells, PLoS One 13(3) (2018) e0193990 (16 pages); https://doi.org/10.1371/journal.pone.0193990
- R. Cao, W. Fan, L. Guo, Q. Ma, G. Zhang, J. Li, X. Chen, Z. Ren and L. Qiu, Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents, Eur. J. Med. Chem. 60 (2013) 135–143; https://doi.org/10.1016/j.ejmech.2012.11.045
- G. D. Kim, Harmine hydrochloride triggers G2/M cell cycle arrest and apoptosis in HCT116 cells through ERK and PI3K/AKT/mTOR signaling pathways, Prev. Nutr. Food Sci. 26(4) (2021) 445–452; https://doi.org/10.3746/pnf.2021.26.4.445
- N. S. R. S. Mota, M. R. Kviecinski, K. B. Felipe, V. M. A. S. Grinevicius, T. Siminski, G. M. Almeida, R. C. Zeferino, C. T. Pich, D. W. Filho and R. C. Pedrosa, β-carboline alkaloid harmine induces DNA damage and triggers apoptosis by a mitochondrial pathway: study in silico, in vitro and in vivo, Int. J. Funct. Nutr. 1(1) (2023) (12 pages); https://doi.org/10.3892/ijfn.2020.1
- D. Shahinas, G. MacMullin, C. Benedict, I. Crandall and D. R. Pillai, Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin, Antimicrob. Agents Chemother. 56(8) (2012) 4207–4213; https://doi.org/10.1128/AAC.00328-12
- S. Kumar, A. Singh, K. Kumar and V. Kumar, Recent insights into synthetic β-carbolines with anti-cancer activities, Eur. J. Med. Chem. 142 (2017) 48–73; https://doi.org/10.1016/j.ejmech.2017.05.059
- D. Jiangkun, D. Wenjia, S. Uwe and W. Junru, β-Carboline alkaloid monomers and dimers: occurrence, structural diversity, and biological activities, Eur. J. Med. Chem. 157 (2018) 622–656; https://doi.org/10.1016/j.ejmech.2018.08.027
- S. Aaghaz, K. Sharma, R. Jain and A. Kamal, β-Carbolines as potential anticancer agents, Eur. J. Med. Chem. 216 (2021) Article ID 113321 (25 pages); https://doi.org/10.1016/j.ejmech.2021.113321
- B. Luo and X. Song, A comprehensive overview of β-carbolines and its derivatives as anticancer agents, Eur. J. Med. Chem. 224 (2021) Article ID 113688 (42 pages); https://doi.org/10.1016/j.ejmech.2021.113688
- J. P. Soni, Y. Yeole and N. Shankaraiah, β-Carboline-based molecular hybrids as anticancer agents: a brief sketch, RSC Med. Chem. 12(5) (2021) 730–750; https://doi.org/10.1039/d0md00422g
- A. Kamboj, B. Sihag, D. S. Brar, A. Kaur and D. B. Salunke, Structure activity relationship in β-carboline derived anti-malarial agents, Eur. J. Med. Chem. 221 (2021) Article ID 113536 (15 pages); https://doi.org/10.1016/j.ejmech.2021.113536
- P. Kushwaha, V. Kumar and B. Saha, Current development of β-carboline derived potential anti-malarial scaffolds, Eur. J. Med. Chem. 252 (2023) Article ID 115247 (15 pages); https://doi.org/10.1016/j.ejmech.2023.115247
- Q. Zhao and G. Huang, Anticancer Hybrids, in Design of Hybrid Molecules for Drug Development (Ed. M. Decker), 1st ed., Elsevier, Amsterdam 2017, pp. 193–218.
- G. Poje, L. Pessanha de Carvalho, J. Held, D. Moita, M. Prudêncio, I. Perković, T. Tandarić, R. Vianello and Z. Rajić, Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents, Eur. J. Med. Chem. 238 (2022) Article ID 114408 (15 pages); https://doi.org/10.1016/j.ejmech.2022.114408
- M. Beus, D. Fontinha, J. Held, Z. Rajić, M. Prudêncio and B. Zorc, Synthesis and antiplasmodial evaluation of novel mefloquine-based fumardiamides, Acta Pharm. 69(2) (2019) 233–248; https://doi.org/10.2478/acph-2019-0019
- G. Barbosa-Lima, A. M. Moraes, A. S. Araújo, E. T. da Silva, C. S. de Freitas, Y. R. Vieira, A. Marttorelli, J. C. Neto, P. T. Bozza, M. V. N. de Souza and T. M. L. Souza, 2,8-Bis(trifluoromethyl)quino-line analogs show improved anti-Zika virus activity, compared to mefloquine, Eur. J. Med. Chem. 127 (2017) 334–340; https://doi.org/10.1016/j.ejmech.2016.12.058
- M. Marinović, G. Poje, I. Perković, D. Fontinha, M. Prudêncio, J. Held, L. Pessanha de Carvalho, T. Tandarić, R. Vianello and Z. Rajić, Further investigation of harmicines as novel antiplasmodial agents: synthesis, structure-activity relationship and insight into the mechanism of action, Eur. J. Med. Chem. 224 (2021) Article ID 113687 (20 pages); https://doi.org/10.1016/j.ejmech.2021.113687
- M. Marinović, I. Perković, D. Fontinha, M. Prudêncio, J. Held, L. Pessanha de Carvalho, T. Tandarić, R. Vianello, B. Zorc and Z. Rajić, Novel harmicines with improved potency against Plasmodium, Molecules 25(19) (2020) Article ID 4376 (19 pages); https://doi.org/10.3390/molecules25194376
- M. Marinović, Amide-type Harmicines as Potential Antimalarial Agents, doctoral dissertation, University of Zagreb Faculty of Pharmacy and Biochemistry, Zagreb 2023, pp 104.
- J. Held, T. Gebru, M. Kalesse, R. Jansen, K. Gerth, R. Müller and B. Mordmüller, Antimalarial activity of the myxobacterial macrolide chlorotonil A, Antimicrob. Agents Chemother. 58(11) (2023) 6378–6384; https://doi.org/10.1128/AAC.03326-14
- H. Noedl, J. Bronnert, K. Yingyuen, B. Attlmayr, H. Kollaritsch and M. Fukuda, Simple histi-dine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing, Antimicrob. Agents Chemother. 49(8) (2005) 3575–3577; https://doi.org/10.1128/AAC.49.8.3575-3577.2005
- R Core Team, R: A language and environment for statistical computing version 4.1.3. R Foundation for Statistical Computing, Vienna, Austria; https://www.R-project.org/; last access December 10, 2022.
- T. J. Maher and D. A. Johson, Receptors and Drug Action, in Foye’s Principles of Medicinal Chemistry (Ed. T. L. Lemke, D. A. Williams, S. W. Zito, Ph. D. Roche, F. Victoria), 6th ed., Lippincott, Williams and Wilkins, Philadelphia, 2007.
- A. K. Ghosh and M. Brindisi, Urea derivatives in modern drug discovery and medicinal chemistry, J. Med. Chem. 63(6) (2020) 2751–2788; https://doi.org/10.1021/acs.jmedchem.9b01541
- K. Pavić, M. Beus, G. Poje, L. Uzelac, M. Kralj and Z. Rajić, Synthesis and biological evaluation of harmirins, novel harmine-coumarin hybrids as potential anticancer agents, Molecules 26(21) (2021) Article ID 6490 (19 pages); https://doi.org/10.3390/molecules26216490